FDA NDC Directory · JSON-LD · Markdown

PANCREAZE

NDC 62541-403 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Generic namePANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
Labeler / ManufacturerVIVUS LLC
Marketing categoryBiologic License Application · App BLA022523
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsPANCRELIPASE AMYLASE (61500 [USP'U]/1)
PANCRELIPASE LIPASE (10500 [USP'U]/1)
PANCRELIPASE PROTEASE (35500 [USP'U]/1)
Marketing started20100412
Package count1

External sources

Source: openFDA. Public-domain (CC0).